Abstract:It has been confirmed that bone morphogenetic protein-9 (BMP-9) promotes the differentiation of osteoblasts. However, the ways in which BMP-9 exerts its effects on the differentiation of osteoclasts and bone resorption remain to be elucidated. The present study was designed to investigate the roles and the molecular mechanism of BMP-9 on the proliferation and differentiation of osteoclast precursors in vitro. Mouse spleen macrophages (RAW 264.7 cells) were cultured in the presence of receptor activator for nuclear factor-kappa b ligand (RANKL) in vitro. Following treatment with different concentrations of BMP-9, a number of parameters were quantitatively monitored. Cell proliferation was determined using an MTT assay. The expression levels of cell BMP receptor-IA (BMPR-IA), BMPR-IB, BMPR-II and anaplastic lymphoma kinase 1 (ALK1) receptor were detected by ELISA, the small mothers against decapentaplegic pathway, extracellular signal-regulated kinase (ERK) 1/2 pathways and markers of osteoclast differentiation were detected by western blotting. The results showed that treatment with BMP-9 alone promoted mouse spleen macrophage proliferation, and the differentiation into osteoclasts occurred only in the presence of RANK. The promoting effect of BMP-9 on cell proliferation and osteoclast differentiation occurred in dose-dependent manner. In addition, BMP-9 significantly upregulated the expression of the ALK1 receptor and inhibited the ERK1/2 pathway. The inhibition of the ERK1/2 pathways was ameliorated by transfection with small interfering (si) RNA ALK1. The effect of BMP-9 on osteoclast differentiation was reduced by transfection with siRNA ALK1, however, the effect was enhanced by the ERK1/2 pathway inhibitor, U0126. The results of the present study demonstrated that BMP-9 promoted the osteoclast differentiation of osteoclast precursors via binding to the ALK1 receptor on the cell surface, and inhibiting the ERK1/2 signaling pathways in the cell.

Dickkopf-1 is involved in BMP9-induced osteoblast differentiation of C3H10T1/2 mesenchymal stem cells

Bone Morphogenetic Protein 9 Regulates the Cross-Talk Between Breast Cancer Cells and Bone Marrow Mesenchymal Stem Cells

Bmp-9-Induced Osteogenic Differentiation of Mesenchymal Progenitors Requires Functional Canonical Wnt/Beta-Catenin Signalling

BMP‐9‐induced osteogenic differentiation of mesenchymal progenitors requires functional canonical Wnt/β‐catenin signalling

Progress in Dickkopf-1-mediated bone metabolism

MiR-9 promotes osteoblast differentiation of mesenchymal stem cells by inhibiting DKK1 gene expression

Dickkopf-1 May Regulate Bone Coupling by Attenuating Wnt/β-Catenin Signaling in Chronic Apical Periodontitis

TGFβ/BMP Type I Receptors ALK1 and ALK2 Are Essential for BMP9-induced Osteogenic Signaling in Mesenchymal Stem Cells

Dickkopf homolog 1 mediates endothelin-1-stimulated new bone formation

Inhibition of ERK1/2 Kinase Enhances BMP9-induced Osteogenic Differentiation of Mesenchymal Stem Cells

Dickkopf-related Protein 3 Negatively Regulates the Osteogenic Differentiation of Rat Dental Follicle Cells.

Wnt3a Enhances Bone Morphogenetic Protein 9-Induced Osteogenic Differentiation of C3H10T1/2 Cells

Bone morphogenetic protein‑9 promotes the differentiation of mouse spleen macrophages into osteoclasts via the ALK1 receptor and ERK 1/2 pathways in vitro.

DDIT3 switches osteogenic potential of BMP9 to lipogenic by attenuating Wnt/β-catenin signaling via up-regulating DKK1 in mesenchymal stem cells

MMP13 promotes the osteogenic potential of BMP9 by enhancing Wnt/β-catenin signaling via HIF-1α upregulation in mouse embryonic fibroblasts

ZBP1 (DAI/DLM-1) promotes osteogenic differentiation while inhibiting adipogenic differentiation in mesenchymal stem cells through a positive feedback loop of Wnt/β-catenin signaling

Notch signaling negatively regulates BMP9-induced osteogenic differentiation of mesenchymal progenitor cells by inhibiting JunB expression.

Bone Morphogenetic Protein-9 Enhances Osteogenic Differentiation of Human Periodontal Ligament Stem Cells Via the JNK Pathway.

Notch signaling pathway promotes osteogenic differentiation of mesenchymal stem cells by enhancing BMP9/Smad signaling

BMP9-regulated Angiogenic Signaling Plays an Important Role in the Osteogenic Differentiation of Mesenchymal Progenitor Cells.

δ EF1 represses BMP-2-induced differentiation of C2C12 myoblasts into the osteoblast lineage